Y. Morales

STATUS EPILEPTICUS: AN INDEPENDENT OUTCOME PREDICTOR AFTER CEREBRAL ANOXIA

P. Kaplan, Y. Morales, Peter W. Kaplan, 2008, Neurology.

CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

B. Weinshenker, R. Ransohoff, C. Lucchinetti, 2005, Journal of neuroimmunology.

CCR5Δ32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis

B. Weinshenker, R. Ransohoff, C. Lucchinetti, 2005, Journal of Neuroimmunology.

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

B. Weinshenker, C. Lucchinetti, W. Brück, 2005, The Lancet.

Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations

C. Lucchinetti, H. Lassmann, W. Bruck, 2007, Multiple sclerosis.

The pathology of multiple sclerosis: evidence for heterogeneity.

J. Parisi, C. Lucchinetti, Y. Morales, 2006, Advances in neurology.